Heart Failure With Preserved Ejection Fraction Clinical Trials in Rochester, Minnesota

6 studies are recruiting for heart failure with preserved ejection fraction in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Exercise Cardiovascular Magnetic Resonance In Heart Failure With Preserved Ejection Fraction

   The purpose of this study is to internally validate low-field Ex-CMR as a noninvasive tool for diagnosing, phenotyping, and risk stratifying HFpEF in patients with exertional dyspnea.

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Mayo Clinic in Rochester, Rochester, Minnesota

   Run by

   Mayo Clinic

   See if you can join NCT07401771 on ClinicalTrials.gov

2. A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure

   The purpose of this study is to assess the performance of 68Ga- FAPI PET in heart failure with preserved ejection fraction (HFpEF)

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Mayo Clinic in Rochester, Rochester, Minnesota

   Run by

   Mayo Clinic

   See if you can join NCT07083011 on ClinicalTrials.gov

3. HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

   HeartShare is a comprehensive study of heart failure, a common and serious medical condition which occurs when the heart is unable to keep up with the demands of the body, resulting in shortness of breath, fluid retention, and fatigue. HeartShare aims to better classify heart failure into subtypes …

   Stage

   Not phased

   Ages

   30 and older

   Site

   Mayo Clinic, Rochester, Minnesota

   Locations

   6 in total

   Run by

   Northwestern University

   See if you can join NCT05873634 on ClinicalTrials.gov

4. Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

   The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new trea…

   Stage

   Not phased

   Ages

   30 and older

   Site

   Mayo Clinic, Rochester, Minnesota

   Locations

   6 in total

   Run by

   Northwestern University

   See if you can join NCT06517186 on ClinicalTrials.gov

5. A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

   To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mayo Clinic, Rochester, Minnesota

   Run by

   Mayo Clinic

   See if you can join NCT07093528 on ClinicalTrials.gov

6. The PeriCut Catheter System Early Feasibility Study (REIMAGINE-HFpEF)

   The PeriCut early feasibility study will evaluate the safety and feasibility of successfully performing a minimally invasive pericardiotomy in patients with heart failure with preserved ejection fraction using the PeriCut Catheter System.

   Stage

   Not phased

   Ages

   30 and older

   Site

   Mayo Clinic, Rochester, Minnesota

   Run by

   Heart Failure Solutions, Inc.

   See if you can join NCT06702501 on ClinicalTrials.gov